You are here: Industry Insights > Respiratory

News List

Poolbeg Pharma dives into nasally administered antivirals pharmatimes
January 17, 2022
If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at...
Organon launches as Women’s Health company expresspharma
June 04, 2021
Organon is a new company focused on women’s health. In India, Organon will be operating in women’s healthcare, fertility, dermatology, respiratory and bone health products in their portfolio.
Inhibrx Announces Enrollment of First Patient in INBRX-101 Study americanpharmaceuticalreview
September 06, 2019
Inhibrx announced the enrollment of the first patient in a Phase 1 clinical trial of INBRX-101. INBRX-101 is an Fc-fusion protein-based therapeutic candidate comprised of a modified recombinant version...
Respiratory virus vaccine receives breakthrough therapy designation europeanpharmaceuticalreview
September 06, 2019
The FDA has awarded a breakthrough therapy designation to an investigational prophylactic vaccine to treat respiratory syncytial virus in seniors.
Cough Sound Analyzer Helps Differentiate Peds Respiratory Disorders drugs
June 11, 2019
Cough Sound Analyzer Helps Differentiate Peds Respiratory Disorders.
Workplace Exposures Contribute to Burden of Respiratory Disease drugs
June 06, 2019
Workplace Exposures Contribute to Burden of Respiratory Disease.
Single vaccination approach developed to combat respiratory diseases europeanpharmaceuticalreview
May 24, 2019
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
HPV Therapy INO-3106 Demonstrates Clinical Efficacy against Rare Respiratory Tract Tumors americanpharmaceuticalreview
April 11, 2019
HPV Therapy INO-3106 Demonstrates Clinical Efficacy against Rare Respiratory Tract Tumors.
AstraZeneca boosts early respiratory medicine with Pieris deal financialexpress
May 04, 2017
Pieris will be responsible for advancing its preclinical lead candidate, PRS-060, into initial Phase I clinical trials in 2017